Introduction
============

The Crb complex, first identified in *Drosophila*, is required for polarity and adhesion in embryonic epithelia, stalk membrane morphogenesis in photoreceptors and for the formation of adherens junctions between cells in the retina \[[@r1]-[@r3]\]. In mice and humans, the Crb complex is involved in retinal integration and organization \[[@r4],[@r5]\].

The human *crumbs homolog 1* (*CRB1*; Gene ID: 23418, OMIM: [604210](http://omim.org/entry/604210)) gene encodes a protein containing a signal peptide, 19 epidermal growth-factor (EGF) domains, three A-globular-like domains, and a transmembrane domain \[[@r6]\]. CRB1 is part of the protein complex at adhesion junctions (AJ) and localized to the external limiting membrane (ELM) in the retina. Mutations in the *CRB1* gene are associated with phenotypically diverse retinal disorders including Leber congenital amaurosis (LCA), early onset retinitis pigmentosa (e.g., RP12), retinitis pigmentosa with coats-like exudative vasculopathy, and pigmented paravenous retinochoroidal atrophy \[[@r7]-[@r13]\]. Four percent of patients with autosomal recessive retinitis pigmentosa (arRP) and 10--15% of patients with autosomal recessive Leber congenital amaurosis (arLCA) carry mutations in the *CRB1* gene \[[@r9]-[@r11]\]. The phenotypic diversity of the patients who carry *CRB1* mutations has led to the hypothesis that environmental and genetic modifiers influence the severity and presentation of *CRB1*-associated retinal degeneration \[[@r11],[@r14],[@r15]\].

The naturally occurring *retinal degeneration 8* (*rd8*) mouse model carries a homozygous single base deletion (c.3481delC) in *Crb1* (*Crb1^rd8/rd8^*) causing early onset retinal degeneration, retinal folds, pseudorosettes, focal retinal dysplasia, and ocular spots \[[@r5]\]. The ocular spots correspond to the retinal folds and pseudorosettes that form due to abnormality in the adherens junctions between the photoreceptors and the Müller glia (MG) cells. The outer nuclear layer (ONL) and the inner nuclear layer (INL) are affected in *rd8* mice. The deletion causes a frameshift resulting in a truncated Crb1 protein that consists of only the N-terminal extracellular domain \[[@r16]\].

Similar to patients carrying *CRB1* mutations, phenotypic variations are observed between and within mice strains homozygous for the *rd8* mutation \[[@r17]\]. It has also been reported that the C57BL/6 lines provided by several commercial vendors harbor the *rd8* mutation and present the characteristic *Crb1-a*ssociated phenotype \[[@r17]\]. Although *rd8* mice of the naturally occurring strain (*Crb1^rd8/rd8^*) exhibit ocular spots in the inferior nasal quadrant, the eyes of mice with the *rd8* mutation on the CAST/EiJ background (*CAST/EiJ^rd8/rd8^*) are reported to have fewer spots than the naturally occurring strain \[[@r5]\]. About 19% of the *CAST/EiJ^rd8/rd8^* mice do not develop ocular spots. Furthermore, N7 generation of *Crb1^rd8/rd8^* backcrossed with C57BL/6J did not develop retinal spots \[[@r5]\]. The retinal histology of the C57BL/6J mice homozygous for the *rd8* mutation are normal, lacking retinal folds and photoreceptor inner segment (IS) disorganization suggesting that the C57BL/6J background is a strong modulator of the *rd8* phenotype. In contrast, C57BL/6N, a sub-strain derived from C57BL/6J after 1951, harbors the *rd8* mutation and invariably expresses the characteristic *Crb1*-associated phenotype \[[@r17]\]. The discrepancies in the *rd8* phenotype between and within mouse strains provide clear evidence that genetic modifiers influence the development of *rd8* pathology. Two genetically related homozygous *rd8* mouse lines obtained from a backcross with *C57BL/6JOlaHsd* mice display variable phenotypes, and a genetic factor on chromosome 15 has been suggested to be responsible for this variation \[[@r18]\].

The early onset ocular phenotypes observed in HLA-A29 transgenic mice and *CCDKO* mice are associated with presence of the *rd8* mutation and are not due to mutations in the HLA-A29, *Ccl2*, or *Cx3cr1* gene \[[@r17]\]. HLA-A29 transgenic and *CCDKO* mice carrying the *rd8* mutation in the homozygous state exhibit retinal dysplasia. Interestingly, about 20--25% of the HLA-A29 transgenic mice with the *rd8* mutation in the heterozygous state also develop dysplasia \[[@r17],[@r19]\]. The genetic background of the *rd8* mutation differentially modulates the retinal phenotype in the original *CCDKO* and the rederived *Ccl2*^−/−^, *Cx3cr1*^−/−^, and *Ccl2*^−/−^/*Cx3cr1*^−/−^ double-knockout mice. The early onset retinal degeneration seen in *Ccl2*^−/−^/*Cx3cr1*^−/−^ double-knockout mice are dependent on the *rd8* mutation, rather than the synergistic effect of both mutations \[[@r19]\].

We previously reported the ocular phenotype of a knock-in mouse model for late-onset retinal degeneration (L-ORD) caused due to a heterozygous S163R mutation in the *Ctrp5* gene \[[@r20]\]. These mice develop a late-onset retinal degeneration phenotype resembling the clinical phenotype observed in patients with L-ORD, including slower rod b-wave recovery, RPE abnormalities, drusen, Bruch's membrane abnormalities including basal laminar deposits, predominant cone photoreceptor loss with onset around age 13 months, followed by rapid progression of retinal degeneration to near complete loss of cones by 21 months, and an age-dependent accumulation of hyperfluorescent spots \[[@r21]-[@r23]\]. Because the L-ORD mouse model (with *Ctrp5*^+/−^ genotype) was developed using embryonic stem (ES) cells from mixed C57BL/6J and C57BL/6N strains and maintained on a C57BL/6J background, we investigated if the rd8 mutation is present in our colonies and whether it influenced the retinal phenotype associated with the *Ctrp5* S163R mutation. The L-ORD mouse model (*Ctrp5*^+/−;^*^rd8/rd8^ and Ctrp5*^+/−;^ *^wt/wt^*) and the wild-type littermate controls (*Wt ^rd8/rd8^* and *Wt ^wt/wt^*) were evaluated for the presence of the *rd8* mutation and its associated phenotype.

Methods
=======

Animals
-------

The L-ORD mice were generated using ES cells derived from mixed C57BL/6J and C57BL/6N strain background mice \[[@r20]\]. These mouse lines were expanded by crossing with the C57BL/6J strain obtained from Jackson Laboratories (Bar Harbor, ME) to maintain the line. Mice with the desired genotype were generated for the current study by selectively breeding the mice in our L-ORD mice colony to generate the required genotypes. All studies were performed using L-ORD mice and wild-type (WT) littermate mice of age groups 6--8, 9--11, 12--14, and 20--21 months. Five mice of each group were used for autofluorescent-scanning laser ophthalmoscopy (AF-SLO) imaging analyses; three to five mice were used for light microscopy and immunohistochemistry (as described below in the Funduscopy section). All mice were maintained according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and with protocols approved by UCSD Institutional Animal Care and Use Committee.

Detection of the *rd8* mutation with allele-specific PCR and sequencing
-----------------------------------------------------------------------

The mice were genotyped, as described previously \[[@r17],[@r20]\]. Mouse tail DNA was isolated with Qiagen reagents following the manufacturer's instructions (Gentra Puregene Mouse Tail Kit, Qiagen, Valencia, CA). Genotyping and sequencing for the *Crb1* c.3481delC and *Ctrp5* S163R mutations were performed using the primers described in [Table 1](#t1){ref-type="table"}.

###### PCR primer for genotyping *Wt ^wt/wt^*,*Wt^rd8/rd8^*, *Ctrp5*^+/−,^*^rd8/rd8^* mice and for amplification of *rd8* locus for sequencing.

  Gene      Allele      Primer name      Sequence (5′-3′)
  --------- ----------- ---------------- ---------------------------------------------------
  *Crb1*    Wild-type   3663-mCrb1 mF1   GTGAAGACAGCTACAGTTCTGATC
                        3665-mCrb1 mR    GCCCCATTTGCACACTGATGAC
  *Crb1*    Mutant      3664-mCrb1 mF2   GCCCCTGTTTGCATGGAGGAAACT TGGAAGACAGCTACAGTTCTTCTG
                        3665-mCrb1 mR    GCCCCATTTGCACACTGATGAC
  *Crb1*    rd8         3666-Crb-F       GGTGACCAATCTGTTGACAATCC
                        3667-Crb-R       GCCCCATTTGCACACTGATGAC
  *Ctrp5*   Knock-in    2855-Ctrp5-F     CCCCTACCTTTCGACCGT
                        2856-Ctrp5-R     GAAGAAAGAGGCGATGGACTG

The allele-specific PCR was performed using m*Crb1*mF1, m*Crb1*mF2, and m*Crb1*mR primers as described earlier \[[@r5]\]. The PCR reaction was carried out in a 20 μl reaction volume containing 1.5 mM MgCl~2~, 100 μM of each dNTP, 1.6 μM each of forward and reverse primer for Wt allele and 0.8 μM of forward and 1.6 μM of reverse primer for rd8 mutate allele with 0.026U AmpliTaq DNA polymerase. Approximately 25 ng of DNA was taken for the reaction. The PCR reaction was initially denatured at 94 °C for 5 min followed by 35 cycles at 94 °C for 30 s, 56 °C for 30 s, 72 °C for 30 s with a final extension of 72 °C for 7 min. Amplification of the wild-type allele produces a 220 bp fragment, and the mutant allele produces a 240 bp fragment. Confirmation of the *rd8* mutation was performed by sequencing the amplicons \[[@r17]\]. Genotyping for the *Ctrp5* S163R knock-in mutation was performed as described earlier \[[@r20]\].

Fundoscopy
----------

Fundoscopy and autofluorescence (AF) imaging were performed using a SPECTRALIS high-resolution, using a SPECTRALIS high-resolution, combination scanning laser ophthalmoscope and spectral domain optical coherence tomography (HRA+OCT) imaging system (Heidelberg Engineering, Inc., Carlsbad, CA) as previously described \[[@r20],[@r24]-[@r26]\]. The number of AF spots per eye was counted, and the average number of AF spots per fundus in each group were calculated.

Retinal histology
-----------------

L-ORD (n=5) and WT (n=5) mice with and without the *rd8* mutation were enucleated and the eyes fixed with the immersion fixation method using 2% paraformaldehyde and 2% glutaraldehyde in 0.1 M phosphate buffer. Eyecups were postfixed in osmium-tannic acid-paraphenylenediamine to preserve neutral lipids \[[@r27]\] before being embedded in Epon 812 per our published methods \[[@r28]\]. Thin sections were examined on a JEM 1200EX II electron (JOEL USA, Inc. Peabody, MA) microscope. Additional eyecups were embedded in methacrylate \[[@r17]\]. Sections (8--10 µm) were stained with hematoxylin and eosin and examined under a light microscope at 20X magnification. Retina cryosections (8--10 μm), obtained from the eyes fixed in 2% paraformaldehyde, were stained for β-catenin using specific antibodies and images were captured with an Olympus FV1000 confocal microscope.

Antibodies
----------

S-opsin antibodies, goat polyclonal (1:200 Chemicon, Temecula, CA), and M-opsin antibody rabbit polyclonal (1:200, Chemicon) were obtained from a commercial source. The anti-mouse secondary antibody conjugated to Alexa fluor 555 and Alexa fluor 488 (1:1,000, Life Technologies, Grand Island, NY) were used to detect the protein expression with immunohistochemistry. β-catenin antibody (1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA) was used to check the integrity of the external limiting membrane (ELM).

Statistical analysis
--------------------

Statistical significance between the number of AF spots in the mutant and wild-type mice was determined using the two-tailed, independent Student *t* test.

Results
=======

Detection of the *rd8* mutation in L-ORD and WT mice
----------------------------------------------------

Analysis of mice in the L-ORD mouse model colony revealed the presence of the *rd8* mutation. The location and identity of the mutation were confirmed with dideoxy sequencing ([Figure 1A](#f1){ref-type="fig"}). In the L-ORD mouse model colony, the *rd8* mutation was detected in the L-ORD mice and the WT littermate controls ([Figure 1B](#f1){ref-type="fig"}). The majority of the mice carried the *rd8* mutation in the homozygous or heterozygous state, while a minor proportion were negative for the *rd8* mutation.

![Detection of the *rd8* mutation with sequencing and agarose gel analysis. **A**: Sequence of the *Crb1* locus showing the wild-type and the c.3481delC mutant allele in the homozygous state. The asterisk denotes the deletion. **B**: Agarose gel electrophoresis showing the migration of PCR amplicons for the *rd8* locus from *Wt* mice (220 bp), mice heterozygous (244 bp and 220 bp) and homozygous (244 bp) for the *rd8* mutation. The DNA ladder was included to indicate the size of amplicons. *Wt^wt/wt^*, *Crb1* wild-type; *Wt^wt/rd8^*, heterozygous for the *Crb1* mutation; *Wt^rd8/rd8^*, homozygous for the *Crb1* mutation.](mv-v21-273-f1){#f1}

Ocular phenotype of L-ORD (*Ctrp5*^+/−;^*^wt/wt^*) and WT littermate control (*Wt^wt/wt^*) mice
-----------------------------------------------------------------------------------------------

The presence of ocular spots is a common finding in L-ORD and *rd8* mice strains. AF-SLO was used to document the ocular phenotype of *Ctrp5*^+/−;^*^wt/wt^* mice (n=5) and age-matched littermates *Wt^wt/wt^* (n=5; [Figure 2](#f2){ref-type="fig"}). Autofluorescent spots were not observed in the 6- to 8-month-old and 9- to 11-month-old *WT^wt/wt^* mice (0±0). Few spots were visualized in the 12- to 14-month-old and 20- to 21-month-old *WT^wt/wt^* mice (23±7 and 70±26, respectively). In contrast, the *Ctrp5^+/−;wt/wt^* mice displayed more spots by 12--14 months (116±72). The accumulation of AF spots in the *Ctrp5*^+/−;^*^wt/wt^* mice was accelerated with age and increased several fold by 20--21 months (1569±105). The AF spots were small and round and distributed evenly throughout the retina in the *Ctrp5*^+/−;^*^wt/wt^* mice.

![Autofluorescence SLO fundus images of L-ORD mice lacking the *rd8* mutation. **A**: Representative autofluorescent-scanning laser ophthalmoscopy (AF-SLO) images of C57BL/6 wild-type control mice free of the *rd8* mutation (*Wt^wt/wt^*) and late-onset retinal degeneration (L-ORD) mice free of the *rd8* mutation (*Ctrp5^+/−;wt/wt^*). The *Wt^wt/wt^* mice showed few AF spots by 21 months. However, the AF spots were significantly increased in the *Ctrp5^+/−;wt/wt^* mice by 21 months of age. Magnification bar=200 μm. **B**: Quantification of the AF spots in *Wt^wt/wt^* (black triangle) and *Ctrp5^+/−;wt/wt^* (black diamond) per the AF-SLO images. The number of AF spots is shown as the mean number of spots ± SD. There was an age-related increase in AF spots (linear regression plot) in both genotypes. However, the AF spots accumulated to a high number in L-ORD mice by 21 months when compared to the age-matched control mice (p\<0.001).](mv-v21-273-f2){#f2}

Retinal morphology of *Ctrp5^+/−;wt/wt^, Wt^wt/wt^, and Wt^rd8/rd8^* mice
-------------------------------------------------------------------------

Retinal morphology was studied to evaluate the integrity of the retinal tissue. The gross retinal morphology of the *Wt^rd8/rd8^* mice was compared with the *Wt^wt/wt^* mice in our L-ORD mouse colony ([Figure 3](#f3){ref-type="fig"}). Both sets of wild-type mice showed normal retinal morphology and lacked the changes associated with the *rd8* genotype at 8 months of age. The INL, ONL, outer plexiform layer (OPL), and outer segments (OS) were normal in these mice. In addition, pseudorosette structures in the OPL and sub-retinal space that are prominent characteristic features of the *rd8* phenotype were absent in all mice.

![Histological analysis of the retina structure of 8-month-old *Wt^wt/wt^* and *Wt^rd8/rd8^* mice. The retinas from 8-month-old *Wt^wt/wt^* and *Wt^rd8/rd8^* mice showed no dysplasia. mo, month; RPE, retinal pigment epithelium; OS, outer segment; IS, inner segment; ELM, external limiting membrane; ONL, outer- nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, glial cell layer. Magnification bar=2 μm.](mv-v21-273-f3){#f3}

The retinal architecture of the *Ctrp5^+/−;wt/wt^* mice was studied up to 21 months and compared with the phenotype of the age-matched *Wt^wt/wt^* littermate control mice ([Figure 4](#f4){ref-type="fig"}). Under light microscopy, these mice did not show significant morphological changes including the abnormalities typically associated with the *rd8* phenotype.

![Histological analysis of the retinal structure of the L-ORD mice. Retinal changes typically associated with the *rd8* phenotype were not observed in either the *Ctrp5^+/−;wt/wt^* or *Wt ^wt/wt^* mice at 20--21 months. In addition, the retinal morphology of these mice lacked gross abnormalities that can be detected with light microscopy. Magnification bar=20 μm.](mv-v21-273-f4){#f4}

Ultrastructural analysis of the RPE was performed on *Ctrp5^+/−;wt/wt^* mice (n=3) at 9, 14, and 21 months. The *Wt^wt/wt^* mice (n=3) aged 21 months were used as a control to compare the pathology ([Figure 5](#f5){ref-type="fig"}). The *Wt^wt/wt^* mice had normal RPE with well-organized basal infoldings and an intact Bruch's membrane. RPE abnormalities were prominent as early as 9 months in the *Ctrp5*^+/−;^*^wt/wt^* mice. The RPE basal infoldings were disorganized and displaced from Bruch's membrane. Numerous vacuoles and phagolysosomes were found throughout the cytoplasm, and several packets of undigested membranous debris were found in the basal RPE. Focal basal laminar deposits and basal linear deposits were found in Bruch's membrane by 14 months. The same abnormalities were also found in the 21-month-old *Ctrp5*^+/−;^*^wt/wt^* mice.

![Ultrastructural analysis of RPE and sub-RPE areas from *Wt^wt/wt^* and Ctrp5*^+/−\ ;wt/wt^* mice. Areas enclosed in boxes in **A**--**D** are magnified in panels **E**--**H**. RPE from control mice (**A**, **E**) showed no abnormalities at 21 months of age. The RPE basal infoldings are organized (star), the cytoplasm is homogenous, and Bruch's membrane is intact (bracket). In contrast, the RPE of the *Ctrp5^+/−,wt/wt^* mice (**B**, **C**, **D**, **F**, **G**, **H**) has structural aberrations beginning at 9 months of age. The RPE basal infoldings are disorganized (stars). Numerous packets of undigested membranous debris are found in the basal RPE (black arrowheads). Multiple vacuoles (white arrows) and phagolysosomes (black arrows) are found throughout the cytoplasm. Focal basal laminar deposits (white arrowheads) are present in Bruch's membrane, as are basal linear deposits (asterisks). All marking are identical to those used in all panels. Magnification bars=200 μm in the top row and 500 μm in the bottom row.](mv-v21-273-f5){#f5}

External limiting membrane is continuous in *Ctrp5^+/−;\ rd8/rd8^* mouse
------------------------------------------------------------------------

To determine whether the loss of *Crb1* affects ELM integrity, we studied the localization of β-catenin in the *Ctrp5^+/−;wt/wt^* and *Ctrp5*^+/−;^*^rd8/rd8^* mice and compared its localization with the *Wt^wt/wt^* mouse retina. The anti-β-catenin antibody strongly stained the ELM in all mice including those with the *rd8* mutation ([Figure 6](#f6){ref-type="fig"}), and the pattern of staining indicated the presence of continuous ELM not only in the *Wt^wt/wt^* mice but also in the mice that had the *rd8* mutation. These results demonstrate the presence of a continuous ELM.

![Continuous ELM staining with anti-adherence junction marker in L-ORD mice homozygous for the *rd8* mutation. **A**--**F** are stained with anti-β-catenin. **A**, **D**: Retinal specimen from *rd8* free wild-type control mouse (*Wt^wt/wt^*) at 9 months of age. **B**, **E**: Retinal specimen from a 5-month-old late-onset retinal degeneration (L-ORD) mouse lacking the *rd8* mutation (*Ctrp5^+/−;wt/wt^*). **C**, **F**: Retinal specimen from a 12-month-old L-ORD mouse homozygous for the *rd8* mutation (*Ctrp5^+/−;rd8/rd8^*). Continuous staining is observed across the ELM in all genotypes. The arrows indicate the ELM. Magnification bar=4 μm. ELM, external limiting membrane, ONL, outer nuclear layer, INL, internal nuclear layer.](mv-v21-273-f6){#f6}

Analysis of previously published *Ctrp5*^+/−^ mice and WT controls for the rd8 genotype and phenotype
-----------------------------------------------------------------------------------------------------

Systematic analysis of the *Ctrp5*^+/−^ mice and their littermate controls was previously described by Chavali et al. \[[@r20]\]. Recent analysis of the tail DNA of the mice reported in Chavali et al. \[[@r20]\] for the *Crb1* mutation revealed that the WT and *Ctrp5*^+/−^ mice presented in that study had the *rd8* genotype either in the heterozygous or homozygous state ([Table 2](#t2){ref-type="table"}). A review of retinal morphology of these mice presented in that publication revealed a lack of the characteristic features of *rd8* pathology in the *Ctrp5*^+/−^ mice and the WT littermate controls up to 21 months \[[@r20]\]. Specifically, pseudorosettes were absent, and morphological changes suggestive of abnormal ELM were not observed. Ultrastructure analysis showed no abnormalities in the retina of the littermate control mice carrying the *rd8* mutation up to 21 months ([Table 2](#t2){ref-type="table"}) \[[@r20]\]. The retinal ultrastructure of the *Ctrp5*^+/−^ mice also had no apparent pathology until 5 months of age. However, in mice older than 12 months, the IS of the rods and cones were mildly swollen.

###### Analysis of mice with L-ORD phenotype presented in Chavali et al. 2011.

  Age (month)                       Genotype (n=3)         Figures (Chavali et al. 2011)   Phenotype                     
  --------------------------------- ---------------------- ------------------------------- ----------- -------- -------- -------
  5                                 *Wt ^rd8^*^/^*^rd8^*   7A,9A                           Absent      Absent   Absent   \>200
  *Ctrp5*^+/−;^ *^rd8^*^/^*^rd8^*   7B,9B,9C               Absent                          Absent      Absent   \>200    
  8                                 *Wt* ^ND^              6A,6B,7C,9D                     Absent      Absent   Absent   \>200
  *Ctrp5*^+/−;^ *^rd8^*^/^*^rd8^*   6A,6B,7D,9E, 9F        absent                          Absent      3±1      \>200    
  12                                *Wt* ^ND^              6A,6B,7E,9G,11                  Absent      Absent   Absent   \>200
  *Ctrp5*^+/−;^ *^rd8^*^/^*^rd8^*   6A,6B,7F,9H,9I,11      Absent                          Absent      56±7     183±7    
  15                                *Wt ^wt^*^/^*^rd8^*    6A,6B,7G,9J,11                  Absent      Absent   15±5     \>200
  *Ctrp5*^+/−;^ *^wt^*^/^*^rd8^*    6A,6B,7H,9K,9L,11      Absent                          Absent      80±10    108±7    
  21                                *Wt* ^ND^              6A,6B,7I,9M,11                  Absent      Absent   25±4     \>200
  *Ctrp5*^+/−;^ *^wt^*^/^*^rd8^*    6A,6B,7J,9N,9O,11      Absent                          Absent      \>200    15±5     

ND: not determined n=number of animals per assessment

Discussion
==========

Analysis of our L-ORD mouse colony on a C57BL/6J background revealed the presence of the *rd8* mutation \[[@r20]\]. In contrast to the findings reported in the original *rd8* strain \[[@r5]\], *Wt^wt/wt^*, *Wt^rd8/rd8^,* and *Ctrp5*^+/−;^ *^rd8^*^/^*^rd8^* mice in our L-ORD mouse colony failed to exhibit the abnormal ocular pathology associated with the *rd8* mutation up to 21 months of age, the longest time point presented in this study. In addition, the *Ctrp5*^+/−^ mice free of the *rd8* mutation developed the characteristic L-ORD-associated pathology.

The *rd8* mice were reported to develop AF lesions that were detected as early as 3 weeks of age \[[@r5]\]. These lesions were large, irregular, and heavily concentrated in the inferior nasal quadrant of the fundus. Clinically, these lesions correspond to the region with retinal folds and pseudorosettes that involve the photoreceptors \[[@r29]\]. The laminar folds and pseudorosettes in *rd8* mice were visualized between the ONL and the INL. Morphologically, they represent displacement of the IS/OS material and the photoreceptor cell bodies into the inner retina due to the incomplete formation of the ELM and loss of the structural barrier \[[@r29]\]. The photoreceptor IS lose their orderly arrangement, and by 4 weeks of age, 25% of photoreceptors are short in the *rd8* mice when compared to WT mice \[[@r5]\]. A significant thinning of the IS and OS in the region with dysplasia was reported in *rd8* mice by 4 weeks of age. By 10 weeks, photoreceptor OS in *rd8* mice start to fragment resulting in the accumulation of granular debris in the sub-retinal space \[[@r5]\].

In contrast to the findings in the original colony of *rd8* mice, the *Wt^rd8/rd8^* and *Ctrp5*^+/−;^ *^rd8^*^/^*^rd8^* mice in our L-ORD mouse colony did not show pseudorosette pathology even at 21 months of age, the oldest age tested in this study. The histology of the mice in the L-ORD colony was devoid of the characteristic features of the *rd8* phenotype. The *Wt^rd8/rd8^* and *Ctrp5^+/−;\ rd8^*^/^*^rd8^* mice showed well-defined nuclear layers (the INL and the ONL). The characteristic retinal changes that are prominent in *rd8* mice as early as 4 weeks were not observed in either the *Wt^rd8/rd8^* or *Ctrp5^+/^*^-;^ *^rd8^*^/^*^rd8^* mice in our colony of L-ORD mice at least up to age 21 months.

The L-ORD mouse model develops AF lesions around 12 months with a subsequent progressive increase in the number of these lesions with age \[[@r20]\]. Contrary to the large number of AF lesions detected in *Ctrp5^+/−;wt/wt^* mice at older ages, a minimal number of spots were observed in the age-matched *Wt^wt/wt^* mice. Although AF lesions in 21-month-old *Ctrp5^+/−;wt/wt^* were distributed throughout the retina, the ocular spots observed in the *rd8* model were larger, heavily concentrated in the inferior quadrant of the fundus, and developed as early as 3 weeks of age. The *rd8* mice backcrossed onto the C57BL/6 background were reported to have a discontinuous ELM phenotype \[[@r5]\]. In contrast, the *Wt^rd8/rd8^* and *Ctrp5*^+/−;^*^rd8/rd8^* mice raised on the C57BL/6J background exhibited an uninterrupted outer limiting membrane. These observations indicate that the presence of the *Crb1* mutation in either the homozygous or heterozygous state failed to result in the development of the characteristic *rd8* phenotype in the *Wt^rd8/rd8^* and *Ctrp5^+^*^/-;^ *^rd8^*^/^*^rd8^* mice in our L-ORD mouse colony. A review of retinal morphology and analysis of the genotype of previously published L-ORD mice and wild-type controls revealed the absence of the *rd8*-associated phenotype at least up to 21 months \[[@r20]\].

In contrast to the findings in the L-ORD mice, the retinal pathology in the *rd8* model is clearly evident by 4 weeks with shortening and swelling of the IS and OS in *rd8* mice \[[@r5]\]. Abnormalities in the laminar architecture and retinal degeneration were also noted \[[@r5],[@r29]\]. However, abnormal drusen-like, basal laminar, and basal linear deposits similar to those observed in the L-ORD mouse model were not reported in *rd8* mice \[[@r20]\]. The inferior retina of the *rd8* mouse is more severely affected with prominent dysplasia than the superior retina. These abnormalities were absent in the L-ORD mice even at 21 months \[[@r20]\]. These observations indicate that the presence of the *Crb1* mutation either in the heterozygous state or homozygous state did not result in the development of the *rd8* characteristic phenotype in the *Ctrp5^+/−^* mice in our L-ORD mouse colony.

The absence of the *rd8* retinal phenotype was noted not only in *Ctrp5*^+/−;^ *^rd8^*^/^*^rd8^* mice but also in the littermate *Wt^rd8/rd8^* mice. This is consistent with the findings reported by Mehalow et al. for C57BL/6J mice \[[@r5]\]. In that study, a significant proportion of mice with a homozygous *Crb1* mutation on the C57BL/6J background did not exhibit *rd8*-associated retinal pathology, including ocular spots, retinal folds, pseudorosettes, inner segment shortening, and disorganization \[[@r5]\]. A more recent study by Luhman et al. reported that the homozygous *rd8* mutation on the C57BL/6 background leads to an increase in evenly distributed small discrete autofluorescent lesions on SLO fundus images \[[@r18]\].

It was hypothesized that the retinal abnormalities due to the *Crb1* mutation are strongly modulated by a genetic variant expressed in C57BL/6J mice \[[@r5]\]. Supporting this hypothesis, Luhmann et al. showed that an autosomal recessive locus in C57BL/6 can modulate the *rd8* phenotype in mice homozygous for the *Crb1* mutation \[[@r18],[@r19]\]. The ES cells used to develop our L-ORD mice were a mixed population obtained from mice with C57BL/6J and C57BL/6N backgrounds. Subsequently, our L-ORD mice were bred with the C57BL/6J strain to maintain the mice line. It is likely that the modifier allele in the C57BL/6J strain is responsible for the absence of the *rd8* phenotype in our L-ORD mouse model colony.

The clinical phenotype of *Ctrp5^+/−;rd8/rd8^* and *Ctrp5^+/−;wt/wt^* mice is similar with characteristic late-onset sub-RPE deposits and Bruch's membrane abnormalities including basal laminar and basal linear deposits. This pathology is consistent with the phenotype observed in patients with L-ORD, while the retinal phenotype of age-matched *Wt^wt/wt^* and *Wt^rd8/rd8^* mice was normal. These observations clearly show that the presence of the *Crb1* mutation did not result in the development of retinal abnormalities in either *Ctrp5^+/−;rd8/rd8^* or littermate *Wt^rd8/rd8^* mice. In addition, these data demonstrate that the S163R mutation in *Ctrp5* in the heterozygous state leads to the development of the L-ORD phenotype and that the presence of *Crb1* mutation did not alter the retinal phenotype in these mice. It is likely that the presence of the *Crb1* mutation in addition to the *Ctrp5* mutation may result in additional changes that were not investigated in this study.

The autofluorescent spots reported by Luhman et al. in C57BL/6 mice with the *Crb1* mutation are similar to the AF lesions observed in *Ctrp5^+/−^* mice \[[@r18]\]. It is possible that the AF lesions observed in *rd8*, *rd6*, *Ctrp5*, and chemokine-deficient mice with diverse genetic abnormalities may have a similar origin, and studying the pathobiology of these lesions may provide better understanding of the mechanism underlying RD.

Although this L-ORD mouse model (*Ctrp5^+/−^*) generated on the C57BL/6J background developed late-onset retinal pathology, another knock-in model with the *Ctrp5* S163R mutation generated on the 129SV background (*Ctrp5*^+/−^-129) did not develop retinal pathology even when older \[[@r30]\]. Shu et al. speculated that the genetic background may also influence the development of L-ORD pathology in mice \[[@r20],[@r30]\]. Our current studies further support this hypothesis, and the identification of the underlying cause of variation in the phenotype between these two mouse models is likely to assist in understanding the molecular pathology of L-ORD and the development of therapeutic interventions to treat this condition.
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